Menu
Not yet recruiting NCT06994026

Feasibility Study of a Relapse Investigation Questionnaire Administered by an MS Care Coordinator Nurse in Patients With Multiple Sclerosis

Observational Multiple Sclerosis Disease Management Feasibility Studies

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Multiple Sclerosis, Disease Management, Feasibility Studies. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study aims to evaluate a questionnaire used by a specialized nurse to help manage relapses in people with multiple sclerosis (MS). The questionnaire is completed during a phone call when the patient reports new or worsening symptoms. It helps the nurse decide whether further tests or treatments are needed, based on a protocol developed with a neurologist. The goal is to improve how quickly and effectively patients receive care during a relapse. The study will include 10 adult patients with active forms of MS over a two-month period.

Primary outcome measures

  • Effectiveness of the relapse investigation questionnaire completed by the MS care coordinator nurse (IDEC) in guiding the patient's care pathway during a suspected relapse, according to the local task-sharing protocol. [Time frame: June 2025 - August 2025]

Eligibility criteria

Inclusion criteria

  • Patients followed by Dr. Manchon for Relapsing-Remitting Multiple Sclerosis or active Secondary Progressive Multiple Sclerosis
  • Adult patients (aged 18 or older)
  • Patients who have provided informed consent for participation in the local task-sharing protocol

Exclusion criteria

  • Pregnant women
  • Minors (under 18 years old)
  • Patients with known renal failure
  • Patients who have not provided or are unable to provide consent for the local task-sharing protocol

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Cohort

Study locations

France · 1 center
  • France — Gonesse

Identifiers

NCT: NCT06994026 · 0062_NEUROLOGIE_TIPO

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗